Dr. Kamaraju is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Froedtert and The Medical College of Wisconsin
Cancer Center, 9200 W.Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-806-4600Fax+1 262-798-7701- Is this information wrong?
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1999 - 2002
Hennepin HealthcareResidency, Internal Medicine, 1996 - 1999
University of Arizona College of Medicine-Tucson (South Campus)Internship, Internal Medicine, 1995 - 1996
Guntur Medical College NTRClass of 1993
Certifications & Licensure
WI State Medical License 2002 - 2025
TX State Medical License 2008 - 2015
MN State Medical License 1998 - 2005
IL State Medical License 2002 - 2002- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Start of enrollment: 2010 Oct 12
- Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study) Start of enrollment: 2021 Oct 05
- A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer Start of enrollment: 2022 Mar 07
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women.Amy Y Lee, Anna T Lyons, Vaia Makris, Melinda R Stolley, Joan M Neuner, Kathryn E Flynn, Sailaja Kamaraju> ;Supportive Care in Cancer. 2024 Apr 2
- Challenges and Solutions to Support Oncology Professionals Serving Underserved Populations With Cancer in the United States: Results From the ASCO Serving the Underser...Patel, M., Hinyard, L., Merrill, J., Smith, K., Lei, J., Hlubocky, F., Fashoyin-Aje, L., Gomez, S., Jeames, S., Carrizosa, D., Kamaraju, S., Kalwar, T., Florez, N., Ki...> ;JCO Oncology Practice. 2024 Feb 14
- Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Dive...Saagar Pamulapati, Meghan Conroy, Chandler Cortina, Eric Harding, Sailaja Kamaraju> ;Archives of Sexual Behavior. 2023 Dec 26
- Join now to see all
Press Mentions
Context Therapeutics® to Present Clinical Data on ONA-XR in Breast Cancer at 2021 San Antonio Breast Cancer SymposiumNovember 19th, 2021
Context Therapeutics and Wisconsin Oncology Network (WON) to Evaluate Apristor Combination Therapy for Women with Advanced Breast CancerOctober 7th, 2019
Professional Memberships
- Member
Hospital Affiliations
Froedtert and the Medical College of Wisconsin Froedtert HospitalMilwaukee, Wisconsin
Clement J. Zablocki Veterans' Administration Medical CenterMilwaukee, Wisconsin- Froedtert West Bend HospitalWest Bend, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
